Oh Hye Jin, Magar Til Bahadur Thapa, Pun Nirmala Tilija, Lee Yunji, Kim Eun Hye, Lee Eung-Seok, Park Pil-Hoon
College of Pharmacy, Yeungnam University, Gyeongsan 38541, Republic of Korea.
Biomol Ther (Seoul). 2018 Mar 1;26(2):191-200. doi: 10.4062/biomolther.2016.276.
Chalcone, (2)-1,3-Diphenylprop-2-en-1-one, and its synthetic derivatives are known to possess anti-oxidative and anti-inflammatory properties. In the present study, we prepared a novel synthetic chalcone compound, ()-1-(4-hydroxyphenyl)-3-(2-(trifluoromethoxy)phenyl)prop-2-en-1-one name (YJI-7), and investigated its inhibitory effects on endotoxin-stimulated production of reactive oxygen species (ROS) and expression of inflammatory mediators in macrophages. We demonstrated that treatment of RAW 264.7 macrophages with YJI-7 significantly suppressed lipopolysaccharide (LPS)-stimulated ROS production. We also found that YJI-7 substantially decreased NADPH oxidase activity stimulated by LPS, indicating that YJI-7 regulates ROS production via modulation of NADPH oxidase in macrophages. Furthermore, YJI-7 strongly inhibited the expression of a number of inflammatory mediators in a gene-selective manner, suggesting that YJI-7 possesses potent anti-inflammatory properties, as well as anti-oxidative activity. In continuing experiments to investigate the mechanisms that could underlie such biological effects, we revealed that YJI-7 suppressed phosphorylation of p38MAPK and JNK stimulated by LPS, whereas no significant effect on ERK was observed. Furthermore, LPS-stimulated production of ROS, activation of NADPH oxidase and expression of inflammatory mediators were markedly suppressed by treatment with selective inhibitor of p38MAPK (SB203580) and JNK (SP600125). Taken together, these results demonstrated that YJI-7, a novel synthetic chalcone derivative, suppressed LPS-stimulated ROS production via modulation of NADPH oxidase and diminished expression of inflammatory mediators, at least in part, via down-regulation of p38MAPK and JNK signaling in macrophages.
查尔酮,即(2)-1,3-二苯基丙-2-烯-1-酮,及其合成衍生物具有抗氧化和抗炎特性。在本研究中,我们制备了一种新型合成查尔酮化合物,即()-1-(4-羟基苯基)-3-(2-(三氟甲氧基)苯基)丙-2-烯-1-酮,命名为(YJI-7),并研究了其对巨噬细胞中内毒素刺激的活性氧(ROS)产生和炎症介质表达的抑制作用。我们证明,用YJI-7处理RAW 264.7巨噬细胞可显著抑制脂多糖(LPS)刺激的ROS产生。我们还发现,YJI-7可显著降低LPS刺激的NADPH氧化酶活性,表明YJI-7通过调节巨噬细胞中的NADPH氧化酶来调节ROS产生。此外,YJI-7以基因选择性方式强烈抑制多种炎症介质的表达,表明YJI-7具有强大的抗炎特性以及抗氧化活性。在继续研究这些生物学效应潜在机制的实验中,我们发现YJI-7可抑制LPS刺激的p38MAPK和JNK磷酸化,而对ERK未观察到显著影响。此外,用p38MAPK选择性抑制剂(SB203580)和JNK选择性抑制剂(SP600125)处理可显著抑制LPS刺激的ROS产生、NADPH氧化酶激活和炎症介质表达。综上所述,这些结果表明,新型合成查尔酮衍生物YJI-7通过调节NADPH氧化酶抑制LPS刺激的ROS产生,并至少部分通过下调巨噬细胞中的p38MAPK和JNK信号来减少炎症介质的表达。